SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time.
Surgery is the standard of care for most patients with solid tumors, and we are working tirelessly to ensure that nobody grieves the loss of a loved one to preventable post-surgical cancer recurrence.
Company Details
- Employees
- 8
- Address
- One Broadway, Cambridge,ma 02142,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://surgetx.com
- HQ
- Cambridge, MA
Surge Therapeutics Questions
Surge Therapeutics's website is http://surgetx.com
Surge Therapeutics's LinkedIn profile is https://www.linkedin.com/company/surge-therapeutics
Surge Therapeutics has
8 employees.
View email and phone details for 8
employees at Surge Therapeutics.
Surge Therapeutics's industry is
Biotechnology Research
Surge Therapeutics's top competitors are
Catalym Gmbh,
Tisento Therapeutics,
Vaxess Technologies,
Kriya Therapeutics, Inc.,
Nexo Therapeutics,
Micropep Technologies,
Primrose Bio,
Scorpion Therapeutics,
Somaí,
Cardurion Pharmaceuticals.
Surge Therapeutics's categories are Biotechnology Research
